Kinsa, the company behind the world’s first FDA-cleared smartphone-connected thermometer has closed $17 million in additional financing from GSR Ventures, Kleiner Perkins Caufield Byers, FirstMark Capital and others. The funds will be used to develop additional smart products and services to further Kinsa’s mission to better track and stop the spread of illness. Features such as wellness tips, real-time fever guidance, medication reminders, connection to physicians, local health information and more are being launched. The latest funding announcement brings Kinsa’s total financing to $28.6 million.
“With this investment, Kinsa is excited to expand our services so we can take a big step forward in our mission to keep families and communities healthy,” explained Inder Singh, founder and CEO of Kinsa. “From the start, our vision has been to use connected health products to engage with people the moment they fall ill, helping them get better and stay well. We’re thrilled that the success of our Smart Thermometers has allowed us to reach this inflection point.”
